PI
GH icon

PEAK6 Investments’s Guardant Health GH Stock Holding History

PEAK6 Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-52,200
Closed -$1.42M – 4531
2022
Q4 		$1.42M Buy
52,200
+15,900
+44% +$728K 0.01% 1628
2022
Q3 		$1.95M Sell
36,300
-14,500
-29% -$744K 0.01% 1581
2022
Q2 		$2.05M Buy
50,800
+34,100
+204% +$1.69M ﹤0.01% 2290
2022
Q1 		$1.11M Buy
+16,700
New +$1.14M ﹤0.01% 2408
2021
Q4 		– Sell
-115,600
Closed -$14.5M – 5352
2021
Q3 		$14.5M Buy
115,600
+3,900
+3% +$463K 0.03% 519
2021
Q2 		$13.9M Sell
111,700
-4,200
-4% -$565K 0.03% 528
2021
Q1 		$17.7M Buy
+115,900
New +$17.5M 0.04% 393
2020
Q1 		– Sell
-1,200
Closed -$94K – 4195
2019
Q4 		$94K Sell
1,200
-200
-14% -$14.4K ﹤0.01% 2885
2019
Q3 		$89K Sell
1,400
-12,100
-90% -$1.07M ﹤0.01% 3258
2019
Q2 		$1.17M Buy
+13,500
New +$1.03M 0.01% 1680

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PEAK6 Investments's GH Position: Q3 2023 in Review

PEAK6 Investments sold out of Guardant Health (GH) in Q3 2023, closing a stake of 5,998 shares — an estimated $215K sold.

PEAK6 Investments first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $2.63M in Q3 2019. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • PEAK6 Investments reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,998 Guardant Health shares in Q3 2023, an estimated $215K.
  • PEAK6 Investments first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
  • PEAK6 Investments's Guardant Health position peaked at $2.63M in Q3 2019.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.